Clinical and Translational Science Awards
The Clinical and Translational Science Awards (CTSA) program in the NCATS Division of Clinical Innovation aims to strengthen and support the entire spectrum of translational research from scientific discovery to improved patient care. Under NCATS leadership, the program supports a national consortium of more than 60 medical research institutions that work together to transform this process. Through this consortium, research teams collaborate to tackle common problems that no one organization can accomplish alone. Its goals are to accelerate the process of translating laboratory discoveries into treatments for patients, train a new generation of clinical and translational researchers, and engage communities in clinical research efforts.
Find out more about the CTSA program, its history and its role in clinical and translational research.
The CTSA program supports funding opportunities for specialized core research facilities and clinical research training. Additional funding opportunities support small business research collaborations and scientific conferences.
Training and Career Development
Learn more about how NCATS trains, cultivates and sustains future leaders of the biomedical research workforce through the CTSA program.
Engaging Communities in Research
To ensure that broad and unique community health needs are addressed, it is crucial for research institutions to collaborate with community organizations throughout the research process. Through the CTSA program, NCATS has facilitated a broad range of programs that engage communities in dialogue about their health concerns and about clinical research.
On Oct. 22, 2013, NIH announced 15 Clinical and Translational Science Awards, expanding the CTSA consortium's reach to New Hampshire. Read the NIH news release.
For More Information
IOM Releases Report on CTSA Program
On June 25, 2013, the Institute of Medicine (IOM) released its findings after reviewing the Clinical and Translational Science Awards (CTSA) program.